Methocarbamol
Methocarbamol is a centrally acting skeletal muscle relaxant used for the short-term relief of discomfort associated with acute musculoskeletal conditions, such as muscle strains, sprains, and painful muscle spasms, alongside rest and physiotherapy. It works by depressing central nervous system activity, helping reduce muscle spasms and associated discomfort, although its precise mechanism is not fully understood. It is commonly available as oral tablets and injectable formulations. Common side effects include drowsiness, dizziness, light-headedness, nausea, and blurred vision. Important precautions include avoiding alcohol and other central nervous system depressants and using caution in patients with liver or kidney impairment. Methocarbamol should be used as prescribed, particularly when driving or operating machinery, because it may impair alertness and coordination.
Methocarbamol was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Methocarbamol, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Methocarbamol from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Methocarbamol, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
